 | Up a level |
Shouval, Roni; Labopin, Myriam; Bomze, David; Baerlocher, Gabriela M.; Capria, Saveria; Blaise, Didier; Hänel, Mathias; Forcade, Edouard; Huynh, Anne; Saccardi, Riccardo; Milone, Giuseppe; Zuckerman, Tsila; Reményi, Péter; Versluis, Jurjen; Esteve, Jordi; Gorin, Norbert Claude; Mohty, Mohamad; Nagler, Arnon (2020). Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission. Bone marrow transplantation, 55(12), pp. 2244-2253. Springer Nature 10.1038/s41409-020-0936-z
Zhou, Zheng; Nath, Rajneesh; Cerny, Jan; Wang, Hai-Lin; Zhang, Mei-Jie; Abdel-Azim, Hisham; Agrawal, Vaibhav; Ahmed, Gulrayz; Al-Homsi, A Samer; Aljurf, Mahmoud; Alkhateeb, Hassan B; Assal, Amer; Bacher, Vera; Bajel, Ashish; Bashir, Qaiser; Battiwalla, Minocher; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; ... (2020). Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood advances, 4(13), pp. 3180-3190. American Society of Hematology 10.1182/bloodadvances.2019001266
Shouval, Roni; Labopin, Myriam; Gorin, Norbert C; Bomze, David; Houhou, Mohamed; Blaise, Didier; Zuckerman, Tsila; Baerlocher, Gabriela M.; Capria, Saveria; Forcade, Edouard; Huynh, Anne; Saccardi, Riccardo; Martino, Massimo; Schaap, Michel; Wu, Depei; Mohty, Mohamad; Nagler, Arnon (2019). Individualized prediction of leukemia-free survival after autologous stem cell transplantation in acute myeloid leukemia. Cancer, 125(20), pp. 3566-3573. John Wiley & Sons 10.1002/cncr.32344
Engel, Nicole; Rovó, Alicia; Badoglio, Manuela; Labopin, Myriam; Basak, Grzegorz W; Beguin, Yves; Guyotat, Denis; Ljungman, Per; Nagler, Arnon; Schattenberg, Anton; Schroeder, Thomas; Schroyens, Wilfried; Tischer, Johanna; Socie, Gerard; Kolb, Hans-Jochem; Tichelli, Andre; Salooja, Nina; Duarte, Rafael F (2019). European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation. Leukemia, 33(2), pp. 508-517. Nature Publishing Group 10.1038/s41375-018-0218-6
Poiré, Xavier; Labopin, Myriam; Polge, Emmanuelle; Blaise, Didier; Chevallier, Patrice; Maertens, Johan; Deconinck, Eric; Forcade, Edouard; Rambaldi, Alessandro; Baerlocher, Gabriela M.; Zuckerman, Tsila; Volin, Liisa; Schouten, Harry C; Ifrah, Norbert; Mohty, Mohamad; Esteve, Jordi; Nagler, Arnon (2019). Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission. American journal of hematology, 94(2), pp. 231-239. Wiley-Liss 10.1002/ajh.25355
Gorin, Norbert Claude; Labopin, Myriam; Blaise, Didier; Dumas, Pierre-Yves; Pabst Müller, Thomas Niklaus; Trisolini, Silvia Maria; Arcese, William; Houhou, Mohamed; Mohty, Mohamad; Nagler, Arnon (2018). Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT. American journal of hematology, 93(7), pp. 859-866. Wiley-Liss 10.1002/ajh.25105
Mathew, Nimitha R; Baumgartner, Francis; Braun, Lukas; O'Sullivan, David; Thomas, Simone; Waterhouse, Miguel; Müller, Tony A; Hanke, Kathrin; Taromi, Sanaz; Apostolova, Petya; Illert, Anna L; Melchinger, Wolfgang; Duquesne, Sandra; Schmitt-Graeff, Annette; Osswald, Lena; Yan, Kai-Li; Weber, Arnim; Tugues, Sonia; Spath, Sabine; Pfeifer, Dietmar; ... (2018). Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells. Nature medicine, 24(3), pp. 282-291. Nature Publishing Group 10.1038/nm.4484
Gorin, Norbert-Claude; Labopin, Myriam; Pabst, Thomas; Remenyi, Peter; Wu, Depei; Huynh, Anne; Volin, Liisa; Cahn, Jean Yves; Yakoub-Agha, Ibrahim; Mercier, Melanie; Houhou, Mohamed; Mohty, Mohamad; Nagler, Arnon (2017). Unrelated matched versus autologous transplantation in adult patients with good and intermediate risk acute myelogenous leukemia in first molecular remission. American journal of hematology, 92(12), pp. 1318-1323. Wiley-Liss 10.1002/ajh.24904
Gorin, Norbert-Claude; Labopin, Myriam; Czerw, Tomasz; Pabst, Thomas; Blaise, Didier; Dumas, Pierre-Yves; Nemet, Damir; Arcese, William; Trisolini, Silvia Maria; Wu, Depei; Huynh, Anne; Zuckerman, Tsila; Meijer, Ellen; Cagirgan, Seckin; Cornelissen, Jan; Houhou, Mohamed; Polge, Emmanuelle; Mohty, Mohamad; Nagler, Arnon (2017). Autologous stem cell transplantation for adult acute myelocytic leukemia in first remission-Better outcomes after busulfan and melphalan compared with busulfan and cyclophosphamide: A retrospective study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Cancer, 123(5), pp. 824-831. John Wiley & Sons 10.1002/cncr.30400
